Takeda Pharmaceutical Co Ltd
(NYSE:TAK)
$
13.45
-0.11 (-0.81%)
Market Cap: 42.99 Bil
Enterprise Value: 70.33 Bil
PE Ratio: 22.63
PB Ratio: 0.94
GF Score: 79/100 Takeda Pharmaceutical Co Ltd at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023 / 07:35PM GMT
Release Date Price:
$15.49
(+1.84%)
Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
Good afternoon. My name is Shinichiro Muraoka, covering Japanese pharma in Morgan Stanley Japan Pharma team. Today, in this session we were with Takeda. Well, I'm extremely pleased to have Costa Saroukos, CFO of Takeda; and Andy Plump, President of R&D. Costa and Andy, thank you for joining us today.
Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
Thank you, Muraoka, for having us. Appreciate it.
Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
Thank you. So sorry, before starting this session, important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/disclosures.
Questions & Answers
Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
So okay, let's get started with
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot